Cisplatin 50mg/50ml vial

Indications:

• Testicular cancer
• Ovarian cancer
• Bladder cancer
• Head and neck cancers
• Lung cancer (non-small cell and small cell types)
• May be used in combination with other chemotherapy medicines for enhanced effectiveness.

Administration:

• Administered only by healthcare professionals via slow intravenous infusion.
• Dose is calculated based on body surface area, type of cancer, and treatment protocol.
• Patients are given pre- and post-hydration with fluids to protect the kidneys.
• Treatment is given in cycles, often every 3–4 weeks.

Safety Information:

• Contraindicated in patients with severe kidney impairment, hearing loss, bone marrow suppression, or allergy to platinum-containing medicines.
• Inform your doctor if you have kidney problems, hearing difficulties, nerve disorders, or prior chemotherapy exposure.
• Common side effects: nausea, vomiting, loss of appetite, fatigue, low blood counts, and hair loss.
• Serious risks: kidney toxicity, hearing loss (ototoxicity), nerve damage (peripheral neuropathy), allergic reactions, and risk of infections due to low immunity.
• Requires regular monitoring of kidney function, blood counts, hearing tests, and electrolyte levels during treatment.

Notice:
Cisplatin 50mg/50ml Vial is a prescription-only chemotherapy medicine. It must only be prepared and administered under the supervision of oncology specialists in a hospital or cancer treatment center.